Literature DB >> 26076935

Prevalence of rheumatic heart disease in 4720 asymptomatic scholars from South Africa and Ethiopia.

Mark E Engel1, Abraham Haileamlak2, Liesl Zühlke3, Carolina E Lemmer1, Simpiwe Nkepu1, Marnie van de Wall1, Wandimu Daniel2, Maylene Shung King4, Bongani M Mayosi1.   

Abstract

BACKGROUND: In Africa, screening for asymptomatic rheumatic heart disease (RHD) has been conducted in single communities using non-standardised echocardiographic criteria. The use of different diagnostic criteria has led to widely variable estimates of the prevalence of RHD in the same communities.
METHODS: Randomly selected school pupils, from 4 to 24 years of age in Bonteheuwel and Langa communities of Cape Town, South Africa, and Jimma, Ethiopia, respectively, were screened for RHD according to standardised evidence-based echocardiographic diagnostic criteria of the World Heart Federation (WHF).
RESULTS: We screened 4720 scholars. In South Africa (n=2720), 1604 (58.9%) were female and the mean age was 12.2±4.2 years. In Ethiopia (n=2000), 1012 (50.6%) were female and the mean age was 10.7±2.5 years. Echocardiographic screening revealed 55 cases of definite and borderline RHD by WHF criteria in South Africa and 61 cases in Ethiopia, corresponding to a prevalence of 20.2 cases per 1000 (95% CI 15.3 to 26.2) and 31 cases per 1000 (95% CI 23.4 to 39.0), respectively. The odds of detecting a scholar with RHD in Ethiopia were 1.5 times higher than in South Africa (OR 1.5; 95% CI 1.04 to 2.2, p=0.02). The prevalence of RHD was 27 cases per 1000 (95% CI 19.3 to 36.8) in Langa, and 12.5 cases per 1000 (95% CI 7.1 to 20.2) in Bonteheuwel. The odds of detecting a schoolchild with RHD in Langa compared with Bonteheuwel were 2.2 (OR 2.2; 95% CI 1.2 to 4.2, p=0.0071).
INTERPRETATION: There were significant differences in detecting asymptomatic RHD in school pupils of different countries and in different communities within a country in sub-Saharan Africa. The variation in the prevalence of RHD between countries and communities has important implications for the modelling of the global burden of RHD. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Mesh:

Year:  2015        PMID: 26076935     DOI: 10.1136/heartjnl-2015-307444

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  32 in total

1.  Echocardiographic screening of 4107 Nigerian school children for rheumatic heart disease.

Authors:  Ekanem N Ekure; Casmir Amadi; Ogochukwu Sokunbi; Nnenna Kalu; Akinsanya Olusegun-Joseph; Oyewole Kushimo; Olayinka Hassan; Desmond Ikebudu; Sophia Onyia; Chinonso Onwudiwe; Victor Nwankwo; Remi Akinwunmi; Fukpode Awusa; Zainab Akere; Olaolu Dele-Salawu; Elizabeth Ajayi; Olagoke Ale; Dorothy Muoneke; Maximillian Muenke; Paul Kruszka; Andrea Beaton; Craig Sable; Adebowale Adeyemo
Journal:  Trop Med Int Health       Date:  2019-04-08       Impact factor: 2.622

Review 2.  The spectrum of heart disease in adults in Malawi: A review of the literature with reference to the importance of echocardiography as a diagnostic modality.

Authors:  Theresa J Allain; Louis Kinley; Bright Tsidya; Ailsa Murray; Mark Cheesman; Sam Kampondeni; Noel Kayange
Journal:  Malawi Med J       Date:  2016-06       Impact factor: 0.875

Review 3.  Cardiovascular disease in Africa: epidemiological profile and challenges.

Authors:  Ashley K Keates; Ana O Mocumbi; Mpiko Ntsekhe; Karen Sliwa; Simon Stewart
Journal:  Nat Rev Cardiol       Date:  2017-02-23       Impact factor: 32.419

4.  Latent Rheumatic Heart Disease: Identifying the Children at Highest Risk of Unfavorable Outcome.

Authors:  Andrea Beaton; Twalib Aliku; Alyssa Dewyer; Marni Jacobs; Jiji Jiang; Chris T Longenecker; Sulaiman Lubega; Robert McCarter; Mariana Mirabel; Grace Mirembe; Judith Namuyonga; Emmy Okello; Amy Scheel; Emmanuel Tenywa; Craig Sable; Peter Lwabi
Journal:  Circulation       Date:  2017-09-27       Impact factor: 29.690

5.  Patterns, outcomes and trends in hospital visits of un-operated and operated children with rheumatic heart disease in Sudan.

Authors:  Sulafa Ali; Noha Karadawi; Nezar B Elhassan; Amal Ahmed M Ahmed; Maha Boctor; Heitham Awadalla; Mohamed H Ahmed
Journal:  Cardiovasc Diagn Ther       Date:  2019-04

6.  Adherence to Benzathine Penicillin G Secondary Prophylaxis and Its Determinants in Patients with Rheumatic Heart Disease at a Cardiac Center of an Ethiopian Tertiary Care Teaching Hospital.

Authors:  Kajela Kibirat Mekonen; Malede Berihun Yismaw; Alfoalem Araba Abiye; Tamrat Assefa Tadesse
Journal:  Patient Prefer Adherence       Date:  2020-02-19       Impact factor: 2.711

7.  Echocardiographic screening for rheumatic heart disease in 4 515 Sudanese school children: marked disparity between two communities.

Authors:  Sulafa Ali; Sara Domi; Bahja Abbo; Rabab Abbas; Tajudeen Bushari; Khalid Al Awad; Abdelrahman Elhassan; Manar E Abdel-Rahman
Journal:  Cardiovasc J Afr       Date:  2018-04-16       Impact factor: 1.167

8.  Handheld echocardiography for screening and control of rheumatic heart disease study in Gezira state, Sudan: a double approach model.

Authors:  Sulafa Ali; Heitham Awadallah; Ahmed Al Hamim; Hussam Al Hussein; Mohamed Al Amin Al Sunni; Tajudeen Bushari; Mohamed H Ahmed
Journal:  Cardiovasc Diagn Ther       Date:  2018-08

9.  Prevalence of rheumatic heart disease among school children in East Africa: a systematic review and meta-analysis.

Authors:  Melaku Bimerew; Biruk Beletew; Addisu Getie; Adam Wondmieneh; Getnet Gedefaw; Asmamaw Demis
Journal:  Pan Afr Med J       Date:  2021-03-08

10.  The natural history of latent rheumatic heart disease in a 5 year follow-up study: a prospective observational study.

Authors:  Liesl Zühlke; Mark E Engel; Carolina E Lemmer; Marnie van de Wall; Simpiwe Nkepu; Alet Meiring; Michael Bestawros; Bongani M Mayosi
Journal:  BMC Cardiovasc Disord       Date:  2016-02-19       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.